Keywords
Antineoplastics
Neoplasms
Patient medication knowledge
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To assess adherence to oral antineoplastic therapy and knowledge about pharmacological treatment in patients treated at the onco-hematology outpatient clinic of a public hospital in Maranhão. Methods: This is an analytical, prospective and cross-sectional study conducted with 50 participants. Adherence assessment was performed using the following instruments: Measure Treatment Adherence (MTA) and a questionnaire designed to describe the sociodemographic and clinical profile and assess patients' knowledge about treatment. Results: The study was composed mainly of female participants (54%) and with a mean age of 55.8 (± 14.53) years. Chronic myeloid leukemia was the most common diagnosis (52%) and hydroxyurea was the most prescribed medication (44%). Most participants had been in treatment for 37 months or more (36%). However, more than 70% were unaware of the purpose of drug therapy. The MTA results highlighted an overall average indicative of adherence to treatment (5.56 ± 0.31), although some questions revealed non-adherence behaviors, such as occasional forgetting to take medication. Conclusion: The results obtained lead to the conclusion that there is good medication adherence in the evaluated public. Knowledge about treatment showed deficits, highlighting the importance of continuing education strategies.
References
ANDRZEJEVSKI VMS, et al. Oral Antineoplastics: Treatment Adherence and Medication Beliefs. Revista Brasileira de Cancerologia, 2021; 67(2): 171189.
BIRAND N, et al. The role of the pharmacist in improving medication beliefs and adherence in cancer patients. Journal of Oncology Pharmacy Practice, 2019; 25(8): 1916-1926.
BRASIL. Instituto Nacional de Câncer. Ministério da Saúde. INCA estima 704 mil casos de câncer por ano no Brasil até 2025. 2022b. Disponível em: https ://www.gov.br/inca/pt-br/assuntos/noticias/2022/inca-estima-704-mil-casos-de-cancer-por-ano-no-brasil-ate-2025. Acesso em: 22 mar. 2024.
BRASIL. Instituto Nacional de Câncer. Ministério da Saúde. O que é Câncer? 2022a. Disponível em: https ://www.gov.br/inca/pt-br/assuntos/cancer/o-que-e-cancer/. Acesso em: 22 mar. 2024.
BRUNTON LL, et al. As Bases Farmacológicas da Terapêutica de Goodman e Gilman. Porto Alegre: AMGH, 2012; 12.
CALADO DS, et al. O papel da atenção farmacêutica na redução das reações adversas associadas ao tratamento de pacientes oncológicos. Revista Brasileira de Educação e Saúde, 2019; 9(3): 94-99.
CIPOLLE, RJ, et al. Pharmaceutical care practice: the patient-centered approach to medication management. New York: McGraw Hill, 2012; 30.
DELGADO AB e LIMA ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicologia, Saúde & Doenças, 2001; 2(2): 81-100.
GARCIA CS, et al. Perfil epidemiológico de pacientes diagnosticados com mieloma múltiplo em hospital de referência para neoplasias malignas hematológicas. RBAC, 2020; 52(3): 248-54.
HOFF PMG. Tratado de Oncologia. São Paulo: Editora Atheneu, 2013.
INCA. INSTITUTO NACIONAL DE Câncer. A avaliação do paciente em cuidados paliativos. Rio de Janeiro: INCA, 2022; 284.
INCA. INSTITUTO NACIONAL DE CÂNCER. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: INCA, 2019; 120.
INSAURRALDE V e VILLAGRA C. Adherencia al tratamiento quimioterápico en pacientes onco-hematológicos y su relación con la calidad de vida. Notas de Enfermería, 2021; 20(37): 23-33.
LEMAY J, et al. Medication adherence in chronic illness: do beliefs about medications play a role? Patient preference and adherence, 2018; 12: 1687-1698.
NEDJAT-HAIEM FR, et al. Financial Hardship and Health Related Quality of Life Among Older Latinos With Chronic Diseases. American Journal of Hospice and Palliative Medicine, 2021; 38(8): 938–946.
OLIVEIRA AT e QUEIROZ APA. Perfil de uso da terapia antineoplásica oral: a importância da orientação farmacêutica. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2012; 3(4): 24-29.
OLIVEIRA DF, et al. Fatores associados à baixa adesão ao tratamento farmacológico de pacientes atendidos por um Centro Integrado de Saúde. Brazilian Journal of Natural Sciences, 2020; 3(3): 430-440.
OPAS. ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE. Câncer. 2020. Disponível em: https ://www.paho.org/pt/topicos/cancer. Acesso em: 22 mar. 2023.
RANGEL CO, et al. Avaliação da adesão ao tratamento com Tamoxifeno por mulheres com câncer de mama. Revista de Epidemiologia e Controle de Infecção, 2020; 10(1): 86-93.
ROSS XS, et al. A review of factors influencing non-adherence to oral antineoplastic drugs. Supportive Care in Cancer, 2020; 28: 4043-4050.
SILVA AG, et al. Adesão de pacientes ao tratamento com antineoplásicos orais: fatores influentes. Revista Baiana de Enfermagem, 2017; 31(1): 16428.
SOLANO M, et al. Oral therapy adherence and satisfaction in patients with multiple Myeloma. Annals of Hematology, 2021; 100(7): 1803-1813.
SPOELSTRA SL e GIVEN CW. Assessment and measurement of adherence to oral antineoplastic agents. Seminars in Oncology Nursing, 2011; 27(2): 116-132.
SUNG H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 2021; 71(3): 209–249.
VIEIRA SC. Oncologia básica para profissionais de saúde. Teresina: EDUFPI, 2016; 1: 172.
VILLAR VCFL, et al. Segurança do paciente no cuidado hospitalar: uma revisão sobre a perspectiva do paciente. Cadernos de saúde pública, 2020; 36(12).
VIRANI A, et al. Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic. Clinical Lymphoma, Myeloma and Leukemia, 2020; 20(9): 543-546.
WAKIUCHI J, et al. Sentidos e dimensões do câncer por pessoas adoecidas-análise estrutural das representações sociais. Revista da Escola de Enfermagem da USP, 2020; 54.
WHO. WORLD HEALTH ORGANIZATION. National cancer control programmes: policies and managerial guidelines, 2nd ed. Geneva, 2002.
WHO. WORLD HEALTH ORGANIZATION. Adherence to long-term therapies: Evidence for action. Geneva, 2003.
YOON S, et al. Factors influencing medication adherence in multi-ethnic Asian patients with chronic diseases in Singapore: A qualitative study. Front Pharmacol, 2023; 14.